2023 · FRONTIERS IN CARDIOVASCULAR MEDICINE

One-year outcomes in cardiogenic shock triggered by ventricular arrhythmia: An analysis of the FRENSHOCK multicenter prospective registry

Cherbi, Miloud, Roubille, Francois, Lamblin, Nicolas, Bonello, Laurent, Leurent, Guillaume, Levy, Bruno, Elbaz, Meyer, Champion, Sebastien, Lim, Pascal, Schneider, Francis, Cariou, Alain, Khachab, Hadi, Bourenne, Jeremy, Seronde, Marie-France, Schurtz, Guillaume, Harbaoui, Brahim, Vanzetto, Gerald, Quentin, Charlotte, Delabranche, Xavier, Aissaoui, Nadia, Combaret, Nicolas, Tomasevic, Danka, Marchandot, Benjamin, Lattuca, Benoit, Henry, Patrick, Gerbaud, Edouard, Bonnefoy, Eric, Puymirat, Etienne, Maury, Philippe, Delmas, Clement

Journal
FRONTIERS IN CARDIOVASCULAR MEDICINE
Année
2023
Volume
10
Article
1092904
Mois
JAN 26
DOI
10.3389/fcvm.2023.1092904

Abstract

Background: Cardiogenic shock (CS) is a life-threatening condition carrying poor prognosis, potentially triggered by ventricular arrhythmia (VA). Whether the occurrence of VA as trigger of CS worsens the prognosis compared to non-VA triggers remains unclear. The aim of this study was to evaluate 1-year outcomes [mortality, heart transplantation, ventricular assist devices (VAD)] between VA-triggered and non-VA-triggered CS.Methods: FRENSHOCK is a prospective multicenter registry including 772 CS patients from 49 centers. One to three triggers can be identified in the registry (ischemic, mechanical complications, ventricular/supraventricular arrhythmia, bradycardia, iatrogenesis, infection, non-compliance). Baseline characteristics, management and 1-year outcomes were analyzed according to the VA-trigger in the CS population.Results: Within 769 CS patients included, 94 were VA-triggered (12.2%) and were compared to others. At 1 year, although there was no mortality difference [42.6 vs. 45.3%, HR 0.94 (0.67-1.30), p = 0.7], VA-triggered CS resulted in more heart transplantations and VAD (17 vs. 9%, p = 0.02). Into VA-triggered CS group, though there was no 1-year mortality difference between ischemic and non-ischemic cardiomyopathies [42.5 vs. 42.6%, HR 0.97 (0.52-1.81), p = 0.92], non-ischemic cardiomyopathy led to more heart transplantations and VAD (25.9 vs. 5%, p = 0.02).Conclusion: VA-triggered CS did not show higher mortality compared to other triggers but resulted in more heart transplantation and VAD at 1 year, especially in non-ischemic cardiomyopathy, suggesting the need for earlier evaluation by advanced heart failure specialized team for a possible indication of mechanical circulatory support or heart transplantation.

Lire l'article complet